International platform trials: as diseases cross borders, so should trials

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	530-531
Number of pages	2
Journal	The Lancet Infectious Diseases
Volume	23
Issue number	5
DOIs	https://doi.org/10.1016/S1473-3099(23)00193-7
Publication status	Published - 23 Mar 2023

Access to Document

@article{b91da449932344d799e8a7f3147dfa78,

title = "International platform trials: as diseases cross borders, so should trials",

author = "LP Derde",

year = "2023",

month = mar,

day = "23",

doi = "10.1016/S1473-3099(23)00193-7",

language = "English",

volume = "23",

pages = "530--531",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Lancet Publishing Group",

number = "5",

}

TY - JOUR

T1 - International platform trials: as diseases cross borders, so should trials

AU - Derde, LP

PY - 2023/3/23

Y1 - 2023/3/23

UR - http://www.scopus.com/inward/record.url?scp=85152587429&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(23)00193-7

DO - 10.1016/S1473-3099(23)00193-7

M3 - Comment/Letter to the editor

C2 - 36966801

SN - 1473-3099

VL - 23

SP - 530

EP - 531

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 5

ER -